Stock listing
A2H63F Stock Price, News, Filings & Events — Spero Therapeutics, Inc.
Selected listing: A2H63F · LS · EUR · DE
The selected listing for Spero Therapeutics, Inc. is A2H63F:LS. Spero Therapeutics focuses on developing innovative therapies for patients with significant unmet medical needs, particularly in the area of antibiotic resistance. Recent news includes updates on their clinical trials and regulatory filings, which are critical for advancing their product pipeline. Investors can stay informed about upcoming events and market developments that may impact the company's performance.
- Ticker
- A2H63F:LS
- Asset type
- Stock
- Market cap
- $68.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Spero Therapeutics, Inc. A2H63F:LS stock context
The selected listing for Spero Therapeutics, Inc. is A2H63F:LS. Spero Therapeutics focuses on developing innovative therapies for patients with significant unmet medical needs, particularly in the area of antibiotic resistance. Recent news includes updates on their clinical trials and regulatory filings, which are critical for advancing their product pipeline. Investors can stay informed about upcoming events and market developments that may impact the company's performance.
Research Spero Therapeutics, Inc.
Spero Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A2H63F:LS.
Spero Therapeutics, Inc. company profile
View the public company page for Spero Therapeutics, Inc. on 6ix.
Spero Therapeutics, Inc. news
Read company news and market updates connected to Spero Therapeutics, Inc..
Spero Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Spero Therapeutics, Inc..
Alternate listings
SPRO:NASDAQ
US · USD
Alternate listing for Spero Therapeutics, Inc.; the primary context on this page is A2H63F:LS.
A2H63F:LSX
DE · EUR
Alternate listing for Spero Therapeutics, Inc.; the primary context on this page is A2H63F:LS.
SPRO:BOATS
US · USD
Alternate listing for Spero Therapeutics, Inc.; the primary context on this page is A2H63F:LS.
2HA:GETTEX
DE · EUR
Alternate listing for Spero Therapeutics, Inc.; the primary context on this page is A2H63F:LS.
2HA:TRADEGATE
DE · EUR
Alternate listing for Spero Therapeutics, Inc.; the primary context on this page is A2H63F:LS.
2HA:DUS
DE · EUR
Alternate listing for Spero Therapeutics, Inc.; the primary context on this page is A2H63F:LS.
2HA:FWB
DE · EUR
Alternate listing for Spero Therapeutics, Inc.; the primary context on this page is A2H63F:LS.
2HA:MUN
DE · EUR
Alternate listing for Spero Therapeutics, Inc.; the primary context on this page is A2H63F:LS.
2HA:SWB
DE · EUR
Alternate listing for Spero Therapeutics, Inc.; the primary context on this page is A2H63F:LS.